357 related articles for article (PubMed ID: 33071164)
1. A Cross-Sectional Study Examining the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in a University Student Population.
Tilley K; Ayvazyan V; Martinez L; Nanda N; Kawaguchi ES; O'Gorman M; Conti D; Gauderman WJ; Van Orman S
J Adolesc Health; 2020 Dec; 67(6):763-768. PubMed ID: 33071164
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of SARS-CoV-2 antibodies and associated risk factors during the second wave of infection in a university community in Cameroon.
Essomba RG; Bayibeki AN; Lissom A; Ateba PT; Seni N; Fouda CAN; Mbitock SBD; Ebonda ND; Afana SD; Akame S; Tembu AA; Ngamaleu MR; Bimai BCB; Kabo O; Nguwoh PS; Ngounouh CT; Meka MCJ; Kengne M; Likeng JN; Kimessoukie EO; Nkoum BA; Assoumou MCO; Fokam J; Yap Boum II; Ambomo MS; Chadou MJP
Influenza Other Respir Viruses; 2023 Nov; 17(11):e13222. PubMed ID: 37964992
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
[TBL] [Abstract][Full Text] [Related]
6. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of Novel Coronavirus SARS-CoV-2 at a Community Hospital Emergency Department and Outpatient Laboratory in Northern Orange County, California.
Yamaki J; Peled H; Mathews S; Park D; Firoozi M; Smith K; Nguyen L
J Racial Ethn Health Disparities; 2021 Dec; 8(6):1551-1555. PubMed ID: 33230735
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study.
Stefanelli P; Bella A; Fedele G; Pancheri S; Leone P; Vacca P; Neri A; Carannante A; Fazio C; Benedetti E; Fiore S; Fabiani C; Simmaco M; Santino I; Zuccali MG; Bizzarri G; Magnoni R; Benetollo PP; Merler S; Brusaferro S; Rezza G; Ferro A
Clin Microbiol Infect; 2021 Apr; 27(4):633.e1-633.e7. PubMed ID: 33253941
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.
Tönshoff B; Müller B; Elling R; Renk H; Meissner P; Hengel H; Garbade SF; Kieser M; Jeltsch K; Grulich-Henn J; Euler J; Stich M; Chobanyan-Jürgens K; Zernickel M; Janda A; Wölfle L; Stamminger T; Iftner T; Ganzenmueller T; Schmitt C; Görne T; Laketa V; Olberg S; Plaszczyca A; Cortese M; Bartenschlager R; Pape C; Remme R; Huzly D; Panning M; Weigang S; Giese S; Ciminski K; Ankerhold J; Kochs G; Schwemmle M; Handgretinger R; Niemeyer CM; Engel C; Kern WV; Hoffmann GF; Franz AR; Henneke P; Debatin KM; Kräusslich HG
JAMA Pediatr; 2021 Jun; 175(6):586-593. PubMed ID: 33480966
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study.
Makaronidis J; Mok J; Balogun N; Magee CG; Omar RZ; Carnemolla A; Batterham RL
PLoS Med; 2020 Oct; 17(10):e1003358. PubMed ID: 33001967
[TBL] [Abstract][Full Text] [Related]
12. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
[TBL] [Abstract][Full Text] [Related]
13. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
14. Coronavirus Disease 2019 Exposure in Surgeons and Anesthesiologists at a New York City Specialty Hospital: A Cross-Sectional Study of Symptoms and SARS-CoV-2 Antibody Status.
Soffin EM; Reisener MJ; Padgett DE; Kelly BT; Sama AA; Zhu J; Salzmann SN; Chiapparelli E; Okano I; Oezel L; Miller AO; Cammisa FP; Girardi FP; Hughes AP
J Occup Environ Med; 2021 Jun; 63(6):521-527. PubMed ID: 34048384
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
[No Abstract] [Full Text] [Related]
16. Seroprevalence of SARS-CoV-2 antibodies among 925 staff members in an urban hospital accepting COVID-19 patients in Osaka prefecture, Japan: A cross-sectional study.
Nishida T; Iwahashi H; Yamauchi K; Kinoshita N; Okauchi Y; Suzuki N; Inada M; Abe K
Medicine (Baltimore); 2021 Jun; 100(25):e26433. PubMed ID: 34160433
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and associated characteristics of anti-SARS-CoV-2 antibodies in Mexico 5 months after pandemic arrival.
Díaz-Salazar C; Sánchez-García A; Rodríguez-Gutiérrez R; Camacho-Ortiz A; Saldívar-Rodríguez D; González-González JG
BMC Infect Dis; 2021 Aug; 21(1):835. PubMed ID: 34412620
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study.
Mahajan S; Srinivasan R; Redlich CA; Huston SK; Anastasio KM; Cashman L; Massey DS; Dugan A; Witters D; Marlar J; Li SX; Lin Z; Hodge D; Chattopadhyay M; Adams MD; Lee C; Rao LV; Stewart C; Kuppusamy K; Ko AI; Krumholz HM
Am J Med; 2021 Apr; 134(4):526-534.e11. PubMed ID: 33130124
[TBL] [Abstract][Full Text] [Related]
19. A Cross-Sectional Analysis of Demographic and Behavioral Risk Factors of Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity Among a Sample of U.S. College Students.
Kianersi S; Ludema C; Macy JT; Garcia Colato E; Chen C; Luetke M; Lown MH; Rosenberg M
J Adolesc Health; 2021 Aug; 69(2):219-226. PubMed ID: 34112598
[TBL] [Abstract][Full Text] [Related]
20. A Cross-Sectional Study of Exposure Factors Associated with Seropositivity for SARS-CoV-2 Antibodies during the Second Epidemic Wave among a Sample of the University of Corsica (France).
Decarreaux D; Sevila J; Masse S; Capai L; Fourié T; Saba Villarroel PM; Amroun A; Nurtop E; Vareille M; Pouquet M; Blanchon T; de Lamballerie X; Charrel R; Falchi A
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
